- A coronavirus vaccine is in development at the University of Pittsburgh’s Center for Vaccine Research.
- The COVID-19 vaccine is based on an existing measles vaccine that has been modified using genetic material from the novel coronavirus.
- Animal trials of the experimental vaccine will first be needed before human trials can be considered. Even if the trials are successful, we could be 18 months away from seeing a coronavirus vaccine become widely available.
- Visit BGR’s homepage for more stories.
Scientists from the University of Pittsburgh’s Center for Vaccine Research are testing out an experimental new vaccine developed using an existing measles vaccine. As KDKA reports, the researchers have genetically modified a measles vaccine using the novel coronavirus, attaching the new genetic material to the vaccine in the hopes that it will prevent the virus from taking root inside a host.
At present, there is no publicly available vaccine to protect against COVID-19, and while a number of research efforts are underway, it will likely still be up to 18 months before we can vaccinate against the virus.
Today’s Top Deals
- 7 exclusive limited-time deals only Amazon Prime members can get
- Today’s best deals: Big Prime-exclusive sale, $24 Roku, $25 earbuds, $8 wireless charger, foam mattress toppers, more
- Amazon’s blowing out Fire tablets at 2020’s lowest prices
Trending Right Now:
- Spring breakers who refused to stop partying now have coronavirus
- CDC launches ‘Coronavirus Self-Checker’ bot to analyze your symptoms
- The early coronavirus infection warning sign you should look out for
Scientists are testing a modified measles vaccine against coronavirus originally appeared on BGR.com on Mon, 23 Mar 2020 at 19:36:25 EDT. Please see our terms for use of feeds.
Read more here:: Boy Genius Report